USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Sister concerns
Welcome to Beacon Pharmaceuticals, a beacon of excellence in the pharmaceutical industry. Our journey is enriched by our diverse portfolio of sister concerns, each contributing to innovation, healthcare solutions, and community well-being. Explore our network of subsidiaries, united in our commitment to advancing healthcare worldwide.
